The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

Oral corticosteroids present significant long-term risks with uncertain evidence for improving asthma outcomes, according to data presented at the American College of Allergy, Asthma & Immunology ...

Medically reviewed by Daniel More, MD Key Takeaways Asthma action plans help maintain good asthma control by outlining ...

Exposure to Mold During Infancy Increases Later Risk for Asthma Visible mold in the homes of infants was associated with a higher risk for asthma development later in childhood; maternal smoking was ...

Symbicort, which is used to treat chronic obstructive pulmonary disease and asthma, can cause side effects. Mild side effects include nasal congestion and headaches. Serious side effects include ...

Though they’re separate conditions, allergic rhinitis and asthma are both atopic diseases. Allergies can trigger asthma, and having asthma can increase your risk for allergic rhinitis. Allergic ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Researchers captured how caregivers view oral ...

ICAAC Severe H1N1 Infection in Children Linked to Asthma and Other Diseases Canadian researchers find that most children with severe H1N1 have comorbid conditions, and a significant percentage require ...